Ixekizumab으로 성공적으로 치료된 전신농포건선 1예
A Patient with Generalized Pustular Psoriasis Successfully Treated with Ixekizumab
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널 순위
- KCI Q2
- 저널
- 대한건선학회지20(2) · pp.67 · 2023
- 피인용
- KCI 0
- ISSN
- 2384-1176
저자
초록
Generalized pustular psoriasis (GPP) is a rare subtype of psoriasis characterized by aseptic pustules accompanied by systemic symptoms, including fever. Treatment options for GPP include various systemic therapies, such as conventional agents and newer biologic agents targeting cytokines like TNF-α, IL-17, and IL-23. We are presenting a case of a young male patient diagnosed with GPP, who experienced recurrent acute exacerbations despite previous treatment attempts with methotrexate, acitretin, cyclosporine, as well as phototherapy. Following an unsuccessful trial with the previous treatments, the patient was switched to ixekizumab, an IL-17 inhibitor, resulting in marked clinical improvement. This case demonstrates that biological agents can be a viable treatment option for generalized pustular psoriasis that shows an inadequate response to other therapeutic approaches.
키워드
식별자
- KCI
- ART003029578



로그인
연구물 목록으로